Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Flonase Sensimist Generic Name & Formulations
Legal Class
OTC
General Description
Fluticasone furoate 27.5mcg; per nasal spray; scent- and alcohol-free.
Pharmacological Class
Steroid.
How Supplied
Spray—9.9mL (60 sprays); 15.8mL (120 sprays)
Manufacturer
Generic Availability
NO
Flonase Sensimist Indications
Indications
Relieves symptoms of hay fever or other upper respiratory allergies. Ocular symptom relief (in patients ≥12yrs).
Flonase Sensimist Dosage and Administration
Adult
Initially 2 sprays in each nostril once daily for Week 1, then 1 or 2 sprays in each nostril once daily as needed for Week 2 through 6 months. Reevaluate after 6 months.
Children
<2yrs: not recommended. Use for the shortest duration necessary to achieve response. ≥2–11yrs: 1 spray in each nostril once daily. Reevaluate after 2 months.
Flonase Sensimist Contraindications
Not Applicable
Flonase Sensimist Boxed Warnings
Not Applicable
Flonase Sensimist Warnings/Precautions
Warnings/Precautions
Not for treating asthma. Injury or surgery to nose that is not fully healed: not recommended. Discontinue if exposed to chicken pox, measles, or tuberculosis. Glaucoma. Cataracts. Discontinue if whistling sound from nose, visual disturbances, severe or frequent nosebleeds occur. Discontinue if no improvement within 7 days after starting or if new symptoms (eg, facial pain, nasal discharge) develop. Avoid eyes or mouth. Pregnancy. Nursing mothers.
Flonase Sensimist Pharmacokinetics
See Literature
Flonase Sensimist Interactions
Interactions
Caution with concomitant ritonavir, ketoconazole, other steroids.
Flonase Sensimist Adverse Reactions
Adverse Reactions
Stinging, sneezing, headaches, dry/irritated nose or throat, nosebleeds, whistling sound, blurred or reduced vision, reduced growth rate in children, allergic reaction (discontinue if occurs).
Flonase Sensimist Clinical Trials
See Literature
Flonase Sensimist Note
Not Applicable
Flonase Sensimist Patient Counseling
See Literature
